A Content Analysis of Nicotine Descriptors on the Front of Vape Packaging in the United Kingdom
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Ford (2025)
A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Azzopardi (2022)
A Novel Nicotine Sublingual Tablet which Mimics Cigarette Smoking Pharamceuticals
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
McCarty (2015)
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell®)
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Dautzenberg et al (2007)
Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Gisleskog et al (2021)
Nicotine replacement therapy versus control for smoking cessation
Individual Clinical
All Categories
Hartmann‐Boyce et al (2025)
Role of nicotine pharmacokinetics in nicotine addiction and nicotine replacement therapy: A review
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Le Houezec (2003)
Safety Profile of a Nicotine Lozenge Compared with That_x000D_of Nicotine Gum in Adult Smokers with Underlying Medical_x000D_Conditions: A 12-Week, Randomized, Open-Label Study
Individual Clinical
Safety
Adverse Effects
Marsh et al (2005)
Effects of nicotine administration via a sublingual tablet on arousal and verbal ability in non-smokers
Individual Clinical
Respiratory Toxicity
Relative Health Effects Of Users
Neumann (2009)
Local Tolerance of a Sublingual Nicotine Tablet, an Open Single-Centre Study
Individual Clinical
Safety
Human Factors
Sand et al (2012)